Similar articles

• [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].

  Zietse R, Weimar W. Zietse R, et al. Ned Tijdschr Geneeskd. 1992 Sep 5;136(36):1749-53. Ned Tijdschr Geneeskd. 1992. PMID: 1407123 Review. Dutch. No abstract available.
• [Effect of cyclosporin A on renal function in patients with glomerulonephritis].

  Heering P, Schneider A, Grabensee B, Plum J. Heering P, et al. Dtsch Med Wochenschr. 2001 Oct 5;126(40):1093-8. doi: 10.1055/s-2001-17603. Dtsch Med Wochenschr. 2001. PMID: 11588659 German.
• Pefloxacin as first-line treatment in nephrotic syndrome.

  Ginsburg C, Toledano D, Deray G, Vlassopoulos D, Baumelou A, Jacobs C. Ginsburg C, et al. Nephrol Dial Transplant. 1994;9(3):335. Nephrol Dial Transplant. 1994. PMID: 8052452 No abstract available.
• [Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome].

  Yoshida M. Yoshida M. Nihon Jinzo Gakkai Shi. 2010;52(1):1-9. Nihon Jinzo Gakkai Shi. 2010. PMID: 20166533 Review. Japanese. No abstract available.
• The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.

  Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ. Lee HY, et al. Clin Nephrol. 1995 Jun;43(6):375-81. Clin Nephrol. 1995. PMID: 7554521 Clinical Trial.